Galacto-oligosaccharides (GOS)

Q: How quickly do GOS modify the microbiota?

Clinical trials detect a significant increase in bifidobacteria within the first week of supplementation. The effect generally stabilizes between two and four weeks. The response varies depending on each person's initial microbiota composition.

Q: What is the difference between GOS and FOS?

GOS consist of galactose chains, FOS of fructose chains. Both are prebiotics, but their structure influences the targeted bacterial populations and digestive tolerance. Clinical data indicate that GOS cause less bloating than FOS at comparable doses.

Q: Are GOS suitable for people following a vegan diet?

GOS are produced enzymatically from lactose, a sugar of dairy origin. The final product may contain traces of residual lactose. Strict vegans who exclude all dairy derivatives should evaluate this information according to their own dietary framework.

Q: Can GOS be taken at any time of day?

No study has demonstrated a difference in efficacy based on time of intake. GOS can be consumed in the morning or evening, with or without a meal. Some people prefer taking them with a meal to reduce initial digestive sensations.

Q: Has long-term GOS supplementation been studied?

The longest clinical trials cover twelve weeks of daily supplementation. The bifidogenic effect is maintained throughout the study period. After discontinuation, bifidobacteria populations gradually return to baseline within a few weeks, indicating that regular intake supports a state without permanently altering it.

Trans-galactooligosaccharides · TOS · Galactooligosaccharides

MicrobiotaMicrobiome & barrier

GOS are prebiotic fibers: undigested by the body, they feed the beneficial bacteria of the colon. The best-established effect concerns bifidobacteria, a bacterial family linked to a balanced gut. Several controlled trials measure their growth within the first week of intake. The same trials report better stool regularity and consistency, proportional to the dose. More moderate results note, after eight weeks in adults over 65, a rise in immune markers. One study also measured improved calcium absorption. Preliminary signals point to morning cortisol and a slight drop in cholesterol, still to be confirmed. With age, the gut flora simplifies and its protective populations recede. Feeding these bacteria first may help maintain solid intestinal ground over time.

Last updated: July 3, 2026

Mechanism of Action

Once ingested, GOS resist gastric digestion and small intestine enzymes. They reach the colon intact. There, specific bacterial families possess the enzymes needed to break them down. This process, called selective fermentation, produces short-chain fatty acids (molecules with two, three or four carbons).

Butyrate provides energy to the cells lining the colon wall. These cells form a barrier between intestinal contents and the bloodstream. The more intact this barrier, the fewer unwanted molecules pass through.

The growth of beneficial bacteria acidifies the intestinal environment. This lower pH inhibits potentially harmful species. The prebiotic effect reshapes the entire ecosystem, beyond merely feeding a few strains.

Key Benefits

Strong
More bifidobacteria in the colon, within the first week of intake: several controlled trials measure this increase, reproducibly, in healthy adults.
Strong
More regular transit and better-formed stools: adult clinical trials report this improvement with GOS, proportional to the dose.
Moderate
More active immune markers after 65: a double-blind randomized trial measures increased phagocytic activity (cells' ability to engulf intruders) after eight weeks of GOS.
Moderate
Better calcium absorption: a controlled study measures it using an isotope tracer (labeled calcium tracked through the body) with GOS in adolescent girls.
Moderate
Lower waking cortisol, the morning stress hormone: a three-week randomized trial observes this in healthy volunteers on GOS, a sign of an effect on the gut-brain axis.
Emerging
A slightly improved lipid profile: preliminary clinical data indicate a modest drop in total cholesterol and triglycerides with GOS, in short-duration trials.

Dosage & Forms

Commercial GOS vary in their polymerisation profile, that is, the distribution of sugar chain lengths. Short chains (DP2-3) dominate the market. Extended-spectrum blends (DP2-8) show a more pronounced bifidogenic effect in clinical trials, meaning stronger stimulation of bifidobacteria. The literature uses doses ranging from 2.5 g to 15 g per day. The consensus for a significant bifidogenic effect in adults is around 5 to 5.5 g per day. This is the dose used in the main randomized trials.

Gradual increase over five to seven days limits initial digestive discomfort. Singular calibrates the dose based on individual profile and other fibers present in the formula.

In the Singular Formula

Inclusion rationale

Non-digestible prebiotic fibers produced by enzymatic transgalactosylation of lactose. GOS (galacto-oligosaccharides) are structurally similar to human milk oligosaccharides (HMOs), the natural fibers that shape the infant microbiota from the very first hours of life. Not digested in the small intestine, GOS reach the colon intact where they are selectively fermented by bifidobacteria and lactobacilli, the bacterial genera that are pillars of a balanced microbiota. This fermentation produces short-chain fatty acids (butyrate, propionate, acetate), energy sources for colonocytes and modulators of intestinal pH. Butyrate nourishes the cells of the colonic mucosa and contributes to intestinal barrier function. GOS differ from FOS (fructo-oligosaccharides) in their galactosidic structure, which gives them superior digestive tolerance with less bloating. In the formula, GOS act upstream of the microbiota by feeding each person's resident bifidobacteria, without relying on colonization delivered by the supplement. Acacia fiber completes this system through slower, more gradual fermentation. This network approach aims to support microbiota diversity, whose decline is a marker of biological aging.

Selected form

Galacto-oligosaccharides (GOS) in soluble fibre form, produced by enzymatic transgalactosylation of lactose. GOS are prebiotics: non-digestible fibres that serve as a selective substrate for beneficial gut bacteria, particularly bifidobacteria. This concentrated form contains a spectrum of oligosaccharide chains from DP2 to DP8 (degree of polymerisation from 2 to 8 galactose units). Slightly sweet taste. May contain traces of residual lactose. Quality: non-GMO.

Formula dosage

0 to 5 g.

Synergies in the formula

GOS act upstream of the microbiota, without relying on colonization delivered by the formula. They feed each person's resident bifidobacteria, whose abundance and diversity vary with dietary history, age and lifestyle. Acacia fiber completes this system through slower, more gradual fermentation, spreading short-chain fatty acid production across the entire colon. Zinc supports intestinal mucosal integrity. By reinforcing the epithelial barrier, it amplifies the protective effect of butyrate produced by GOS fermentation. Vitamin D3 modulates the intestinal immune response and helps regulate tight junctions between mucosal cells. These two bioactives act downstream of GOS, on the structures that prebiotic fermentation helps nourish.

Safety & Precautions

GOS have a long history of safe use. Naturally present in breast milk as structurally similar oligosaccharides, they are part of human nutrition from birth. Clinical trials report a favorable tolerance profile at studied doses (up to 15 g per day). Adverse effects are limited to mild bloating or flatulence, transient and reduced by gradual introduction over five to seven days.

Individuals with significant lactose sensitivity should note the possible presence of residual traces. GOS are not recommended for people with galactosemia (a rare genetic condition that prevents galactose metabolism). Pregnant or breastfeeding women can consume GOS as part of a balanced diet. For any specific health situation, consulting a healthcare professional is recommended.

Scientific Studies

Authors	Year	Type	Journal
Vulevic J et al.	2013	Randomised Controlled Trial	The Journal of Nutrition	View on PubMed
A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults Double-blind randomized trial in 45 overweight adults: GOS supplementation reduces inflammatory markers, total cholesterol and favorably modulates fecal microbiota.
Vulevic J et al.	2008	Randomised Controlled Trial	The American Journal of Clinical Nutrition	View on PubMed
Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers Double-blind randomized trial in 44 healthy volunteers over 64: GOS (5.5 g/d, 10 weeks) increase bifidobacteria and improve phagocytic activity.
Schmidt K et al.	2015	Randomised Controlled Trial	Psychopharmacology	View on PubMed
Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers Randomized trial in 45 healthy volunteers: three weeks of GOS reduce waking salivary cortisol and decrease attentional bias toward negative stimuli.
Whisner CM et al.	2013	Randomised Controlled Trial	British Journal of Nutrition	View on PubMed
Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial Double-blind crossover trial in adolescent girls: GOS increase calcium absorption measured by isotope tracer and fecal bifidobacteria.
Silk DB et al.	2009	Randomised Controlled Trial	Alimentary Pharmacology & Therapeutics	View on PubMed
Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome Clinical trial in 44 individuals with functional bowel disorders: GOS (3.5 g/d then 7 g/d) increase bifidobacteria and improve subjective intestinal comfort.
Davis LM et al.	2011	Randomised Controlled Trial	PLoS ONE	View on PubMed
Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans Study using pyrosequencing in 18 healthy adults: GOS produce a highly specific bifidogenic response, selectively increasing certain bifidobacterial species.
Davani-Davari D et al.	2019	Systematic Review	Foods	View on PubMed
Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications Comprehensive review of prebiotics including GOS: selective fermentation mechanisms, clinical data on bifidogenic and immunomodulatory effects in humans.

Frequently Asked Questions

How quickly do GOS modify the microbiota?#[ + ]

What is the difference between GOS and FOS?#[ + ]

Are GOS suitable for people following a vegan diet?#[ + ]

Can GOS be taken at any time of day?#[ + ]

Has long-term GOS supplementation been studied?#[ + ]

Discover all our bioactives